Noesis Capital Mangement Corp Eli Lilly & CO Transaction History

Noesis Capital Mangement Corp

$504 Billion
Q3 2024

A detailed history of Noesis Capital Mangement Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Noesis Capital Mangement Corp holds 297 shares of LLY stock, worth $235,859. This represents 0.05% of its overall portfolio holdings.

Number of Shares

297

Previous 307 3.26%

Holding current value

$235,859

Previous $278 Million 5.33%

% of portfolio

0.05%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $7,721 - $9,600	-10 Reduced 3.26%	297 $263 Million
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $6,523 - $8,181	-9 Reduced 2.85%	307 $278 Million
Q1 2024 May 03, 2024	SELL	$592.2 - $792.28 $368,940 - $493,590	-623 Reduced 66.35%	316 $246 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $5,251 - $6,191	-10 Reduced 1.05%	939 $547 Million
Q3 2023 Nov 03, 2023	SELL	$434.7 - $599.3 $19,561 - $26,968	-45 Reduced 4.53%	949 $510 Million
Q2 2023 Jul 31, 2023	SELL	$350.74 - $468.98 $21,044 - $28,138	-60 Reduced 5.69%	994 $466 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $9,318 - $10,944	-30 Reduced 2.77%	1,054 $362 Million
Q3 2022 Nov 01, 2022	SELL	$296.48 - $337.87 $39,431 - $44,936	-133 Reduced 10.93%	1,084 $351 Million
Q2 2022 Jul 29, 2022	SELL	$278.73 - $327.27 $8,361 - $9,818	-30 Reduced 2.41%	1,217 $394,000
Q1 2022 May 05, 2022	SELL	$234.69 - $291.66 $390,054 - $484,738	-1,662 Reduced 57.13%	1,247 $357,000
Q4 2021 Feb 03, 2022	BUY	$224.85 - $279.04 $67,455 - $83,712	300 Added 11.5%	2,909 $803,000
Q3 2021 Nov 04, 2021	BUY	$221.6 - $272.71 $277,000 - $340,887	1,250 Added 91.98%	2,609 $602,000
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $10,652 - $13,778	-59 Reduced 4.16%	1,359 $311,000
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $6,901 - $8,934	-42 Reduced 2.88%	1,418 $264,000
Q1 2020 May 06, 2020	SELL	$119.05 - $147.35 $23,810 - $29,470	-200 Reduced 12.05%	1,460 $202,000
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $177,487 - $219,833	1,660 New	1,660 $218,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Noesis Capital Mangement Corp, based on Form 13F filings with the SEC.

News

Stay updated on Noesis Capital Mangement Corp with notifications on news.

Account

Noesis Capital Mangement Corp Eli Lilly & CO Transaction History